TS-143

DRUG3 trials

Sponsors

Taisho Pharmaceutical Co., Ltd.

Conditions

Chronic Kidney DiseaseHealthy Participants

Phase 1

Clinical Pharmacology Study of TS-143 in Nondialysis and Hemodialysis Patients with Chronic Kidney Disease

CompletedNCT03581071

Taisho Pharmaceutical Co., Ltd.Chronic Kidney Disease

Start: 2016-10-06End: 2017-07-06Updated: 2025-02-28

Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration)

CompletedNCT03591133

Taisho Pharmaceutical Co., Ltd.Healthy Participants

Start: 2015-12-24End: 2016-04-14Updated: 2025-02-28

Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration)

CompletedNCT03595202

Taisho Pharmaceutical Co., Ltd.Healthy Participants

Start: 2017-04-03End: 2017-07-07Updated: 2025-02-28